Cargando…

The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form

A stability-indicating ultra-high-performance liquid chromatography (UHPLC) method with a diode array detector was developed and validated for the determination of cis/trans isomers of perindopril l-arginine in bulk substance and pharmaceutical dosage form. The separation was achieved on a Poroshell...

Descripción completa

Detalles Bibliográficos
Autores principales: Paczkowska, Magdalena, Zalewski, Przemysław, Garbacki, Piotr, Talaczyńska, Alicja, Krause, Anna, Cielecka-Piontek, Judyta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224746/
https://www.ncbi.nlm.nih.gov/pubmed/25400289
http://dx.doi.org/10.1007/s10337-014-2724-7
_version_ 1782343394655207424
author Paczkowska, Magdalena
Zalewski, Przemysław
Garbacki, Piotr
Talaczyńska, Alicja
Krause, Anna
Cielecka-Piontek, Judyta
author_facet Paczkowska, Magdalena
Zalewski, Przemysław
Garbacki, Piotr
Talaczyńska, Alicja
Krause, Anna
Cielecka-Piontek, Judyta
author_sort Paczkowska, Magdalena
collection PubMed
description A stability-indicating ultra-high-performance liquid chromatography (UHPLC) method with a diode array detector was developed and validated for the determination of cis/trans isomers of perindopril l-arginine in bulk substance and pharmaceutical dosage form. The separation was achieved on a Poroshell 120 Hilic (4.6 × 150 mm, 2.7 µm) column using a mobile phase composed of acetonitrile–0.1 % formic acid (20:80 v/v) at a flow rate of 1 mL min(−1). The injection volume was 5.0 µL and the wavelength of detection was controlled at 230 nm. The selectivity of the UHPLC-DAD method was confirmed by determining perindopril l-arginine in the presence of degradation products formed during acid–base hydrolysis and oxidation as well as degradation in the solid state, at an increased relative air humidity and in dry air. The method’s linearity was investigated in the ranges 0.40–1.40 µg mL(−1) for isomer I and 0.40–2.40 µg mL(−1) for isomer II of perindopril l-arginine. The UHPLC-DAD method met the precision and accuracy criteria for the determination of the isomers of perindopril l-arginine. The limits of detection and quantitation were 0.1503 and 0.4555 µg mL(−1) for isomer I and 0.0356 and 0.1078 µg mL(−1) for isomer II, respectively.
format Online
Article
Text
id pubmed-4224746
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-42247462014-11-12 The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form Paczkowska, Magdalena Zalewski, Przemysław Garbacki, Piotr Talaczyńska, Alicja Krause, Anna Cielecka-Piontek, Judyta Chromatographia Short Communication A stability-indicating ultra-high-performance liquid chromatography (UHPLC) method with a diode array detector was developed and validated for the determination of cis/trans isomers of perindopril l-arginine in bulk substance and pharmaceutical dosage form. The separation was achieved on a Poroshell 120 Hilic (4.6 × 150 mm, 2.7 µm) column using a mobile phase composed of acetonitrile–0.1 % formic acid (20:80 v/v) at a flow rate of 1 mL min(−1). The injection volume was 5.0 µL and the wavelength of detection was controlled at 230 nm. The selectivity of the UHPLC-DAD method was confirmed by determining perindopril l-arginine in the presence of degradation products formed during acid–base hydrolysis and oxidation as well as degradation in the solid state, at an increased relative air humidity and in dry air. The method’s linearity was investigated in the ranges 0.40–1.40 µg mL(−1) for isomer I and 0.40–2.40 µg mL(−1) for isomer II of perindopril l-arginine. The UHPLC-DAD method met the precision and accuracy criteria for the determination of the isomers of perindopril l-arginine. The limits of detection and quantitation were 0.1503 and 0.4555 µg mL(−1) for isomer I and 0.0356 and 0.1078 µg mL(−1) for isomer II, respectively. Springer Berlin Heidelberg 2014-08-13 2014 /pmc/articles/PMC4224746/ /pubmed/25400289 http://dx.doi.org/10.1007/s10337-014-2724-7 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Short Communication
Paczkowska, Magdalena
Zalewski, Przemysław
Garbacki, Piotr
Talaczyńska, Alicja
Krause, Anna
Cielecka-Piontek, Judyta
The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title_full The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title_fullStr The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title_full_unstemmed The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title_short The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form
title_sort development and validation of a stability-indicating uhplc-dad method for determination of perindopril l-arginine in bulk substance and pharmaceutical dosage form
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224746/
https://www.ncbi.nlm.nih.gov/pubmed/25400289
http://dx.doi.org/10.1007/s10337-014-2724-7
work_keys_str_mv AT paczkowskamagdalena thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT zalewskiprzemysław thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT garbackipiotr thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT talaczynskaalicja thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT krauseanna thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT cieleckapiontekjudyta thedevelopmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT paczkowskamagdalena developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT zalewskiprzemysław developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT garbackipiotr developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT talaczynskaalicja developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT krauseanna developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform
AT cieleckapiontekjudyta developmentandvalidationofastabilityindicatinguhplcdadmethodfordeterminationofperindoprillarginineinbulksubstanceandpharmaceuticaldosageform